Tower NZ weathers economic slowdown
Tower Limited, the New Zealand arm of the group, has reported growth in its life insurance and overall profit despite some pain in its investment management division.
Group managing director Rob Flannagan said the New Zealand business is “not distracted by overseas relationships”, and added the group’s “underlying strengths will serve it well in a slowing economy”.
While the group’s pre-tax earnings were down on last year, profit after tax was up.
In its second annual report after splitting from Tower Australia in November 2006, Tower Limited reported net profit after tax (NPAT) of NZ$40.5 million for the year to September 30, 2008. This was up NZ$5.2 million on last year’s result of NZ$34.6 million.
Total revenue from continuing operations was down 5.5 per cent to NZ$454.8 million.
The group reported a NZ$5.8 million increase in NPAT in its health and life business to NZ$28.5 million, while reporting NPAT in its Tower Investments business of NZ$3.7 million, down from NZ$7.6 million last year. The group said this was the result of reduced funds under management and ongoing expenses related to Kiwisaver and portfolio investment entity systems.
The annualised return on shareholder funds was up slightly to 14.7 per cent, with the group to pay an after tax dividend of 8 cents per share fully imputed.
The group has a conservative gearing ratio of 14.6 per cent.
Recommended for you
Determinations by the FSCP since the start of 2025 are almost double the number in the same period of 2024, with non-concessional contribution cap errors and incorrect advice among the issues.
Whether received via human or digital means, financial advice is reportedly leading to lower stress and more confidence, according to Vanguard.
The new financial year has got off to a strong start in adviser gains, helped by new entrants, after heavy losses sustained in June.
Michael McCorry, chief investment officer at BlackRock Australia, has detailed how investors are reconsidering their 60/40 portfolios as macro uncertainty highlight the benefits of liquid alternatives.